Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$197.69 - $227.29 $24,908 - $28,638
-126 Reduced 11.05%
1,014 $230,000
Q3 2023

Nov 02, 2023

SELL
$201.05 - $221.7 $13,671 - $15,075
-68 Reduced 5.63%
1,140 $229,000
Q2 2023

Aug 04, 2023

SELL
$211.93 - $241.33 $15,258 - $17,375
-72 Reduced 5.63%
1,208 $291,000
Q1 2023

May 05, 2023

BUY
$213.32 - $257.83 $639 - $773
3 Added 0.23%
1,280 $293,000
Q4 2022

Feb 13, 2023

BUY
$203.72 - $248.97 $6,519 - $7,967
32 Added 2.57%
1,277 $300,000
Q3 2022

Nov 07, 2022

SELL
$204.81 - $262.19 $3,276 - $4,195
-16 Reduced 1.27%
1,245 $255,000
Q2 2022

Aug 05, 2022

SELL
$213.86 - $277.87 $28,871 - $37,512
-135 Reduced 9.67%
1,261 $296,000
Q1 2022

May 09, 2022

SELL
$259.82 - $298.18 $7,794 - $8,945
-30 Reduced 2.1%
1,396 $368,000
Q4 2021

Feb 07, 2022

SELL
$271.6 - $314.21 $118,960 - $137,623
-438 Reduced 23.5%
1,426 $448,000
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $113,225 - $127,036
-412 Reduced 18.1%
1,864 $525,000
Q2 2021

Aug 05, 2021

SELL
$251.87 - $278.14 $74,805 - $82,607
-297 Reduced 11.54%
2,276 $628,000
Q1 2021

May 05, 2021

SELL
$204.88 - $255.03 $227,621 - $283,338
-1,111 Reduced 30.16%
2,573 $656,000
Q4 2020

Feb 08, 2021

SELL
$186.91 - $214.42 $41,680 - $47,815
-223 Reduced 5.71%
3,684 $749,000
Q3 2020

Nov 05, 2020

SELL
$167.03 - $201.3 $73,827 - $88,974
-442 Reduced 10.16%
3,907 $735,000
Q2 2020

Aug 05, 2020

SELL
$113.31 - $182.44 $145,036 - $233,523
-1,280 Reduced 22.74%
4,349 $722,000
Q1 2020

May 01, 2020

SELL
$104.32 - $195.28 $157,210 - $294,286
-1,507 Reduced 21.12%
5,629 $711,000
Q4 2019

Feb 06, 2020

SELL
$163.48 - $173.61 $225,111 - $239,060
-1,377 Reduced 16.18%
7,136 $1.21 Million
Q3 2019

Nov 01, 2019

SELL
$159.77 - $178.1 $13,101 - $14,604
-82 Reduced 0.95%
8,513 $1.43 Million
Q2 2019

Aug 01, 2019

SELL
$144.16 - $172.9 $270,155 - $324,014
-1,874 Reduced 17.9%
8,595 $1.49 Million
Q1 2019

Apr 30, 2019

SELL
$123.7 - $156.3 $302,199 - $381,840
-2,443 Reduced 18.92%
10,469 $1.6 Million
Q4 2018

Feb 06, 2019

SELL
$120.82 - $174.09 $87,594 - $126,215
-725 Reduced 5.32%
12,912 $1.63 Million
Q3 2018

Oct 29, 2018

SELL
$167.67 - $188.27 $1.34 Million - $1.5 Million
-7,983 Reduced 36.92%
13,637 $2.37 Million
Q2 2018

Jul 27, 2018

SELL
$160.33 - $189.41 $54,832 - $64,778
-342 Reduced 1.56%
21,620 $3.88 Million
Q1 2018

May 11, 2018

BUY
$161.53 - $178.11 $295,599 - $325,941
1,830 Added 9.09%
21,962 $3.55 Million
Q4 2017

Jan 31, 2018

SELL
$147.99 - $163.95 $101,669 - $112,633
-687 Reduced 3.3%
20,132 $3.21 Million
Q3 2017

Nov 02, 2017

BUY
$149.47 - $160.56 $3.11 Million - $3.34 Million
20,819
20,819 $3.14 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.